Skip to main content
Erschienen in: Indian Journal of Hematology and Blood Transfusion 2/2019

11.10.2018 | Original Article

Psychiatric Disorders and Quality of Life in Egyptian Patients with Chronic Immune Thrombocytopenic Purpura: A Single Center Study

verfasst von: Sohier Yahia, Yahya Wahba, Abdel-Hady El-Gilany, Suzy Abdelmabood, Mohamed Adel El-Hadidy, Ahmad Darwish, Ahmed K. Mansour

Erschienen in: Indian Journal of Hematology and Blood Transfusion | Ausgabe 2/2019

Einloggen, um Zugang zu erhalten

Abstract

The impact of chronic immune thrombocytopenic purpura (ITP) on the psychological health and quality of life is evident among children and adolescents. We aimed to describe psychological disorders and assess quality of life in children with chronic ITP and compared their results with their healthy peers. A cross-sectional comparative study was carried out in a tertiary care university-affiliated hospital during a period from November, 2015 till April, 2018. We enrolled 119 children with chronic ITP and compared with 220 healthy peers. Relevant demographic and clinical data were collected and statistically analyzed. Quality of life for both patients and control groups was measured using pediatric quality of life inventory version 4 (Arabic one). Also psychiatric evaluation of both groups was done using Arabic version of Mini-International Neuropsychiatric Interview for Children (Mini-KID). Majority of patients (90.7%) exhibited mucocutaneous bleeding. Most of patients (61.3%) did not need any definitive treatment for chronic ITP while 38.6% received second line therapy. About one-third of the patients needed rescue medications to control active bleeding. The scores of all sub-scales of Peds QL 4.0 were significantly decreased among patients group when compared to their healthy peers (P < 0.001). General anxiety disorder and oppositional defiant disorders were the commonest psychiatric disorders among children with chronic ITP. Quality of life in children with chronic ITP is markedly impaired with occurrence of a variable spectrum of psychiatric disorders among the studied patients.
Literatur
3.
Zurück zum Zitat Zufferey A, Kapur R, Semple JW (2017) Pathogenesis and therapeutic mechanisms in immune thrombocytopenia (ITP). J Clin Med 6:16CrossRefPubMedCentral Zufferey A, Kapur R, Semple JW (2017) Pathogenesis and therapeutic mechanisms in immune thrombocytopenia (ITP). J Clin Med 6:16CrossRefPubMedCentral
4.
5.
Zurück zum Zitat George JN (2006) Management of patients with refractory immune thrombocytopenic purpura. J Thromb Haemost 4:1664–1672CrossRefPubMed George JN (2006) Management of patients with refractory immune thrombocytopenic purpura. J Thromb Haemost 4:1664–1672CrossRefPubMed
6.
Zurück zum Zitat Yong M, Schoonen WM, Li L et al (2010) Epidemiology of paediatric immune thrombocytopenia in the general practice research database. Br J Haematol 149:855–864CrossRefPubMed Yong M, Schoonen WM, Li L et al (2010) Epidemiology of paediatric immune thrombocytopenia in the general practice research database. Br J Haematol 149:855–864CrossRefPubMed
7.
Zurück zum Zitat Terrell DR, Beebe LA, Vesely SK et al (2010) The incidence of immune thrombocytopenic purpura in children and adults: a critical review of published reports. Am J Hematol 85:174–180CrossRefPubMed Terrell DR, Beebe LA, Vesely SK et al (2010) The incidence of immune thrombocytopenic purpura in children and adults: a critical review of published reports. Am J Hematol 85:174–180CrossRefPubMed
8.
Zurück zum Zitat Neunert CE, Buchanan GR, Blanchette V et al (2009) Relationships among bleeding severity, health-related quality of life, and platelet count in children with immune thrombocytopenic purpura. Pediatr Blood Cancer 53:652–654CrossRefPubMed Neunert CE, Buchanan GR, Blanchette V et al (2009) Relationships among bleeding severity, health-related quality of life, and platelet count in children with immune thrombocytopenic purpura. Pediatr Blood Cancer 53:652–654CrossRefPubMed
9.
Zurück zum Zitat Alesci SR, Schwan V, Miesbach W et al (2013) Rare bleeding disorders are associated with depression and anxiety. Hamostaseologie 33:S64–S68PubMed Alesci SR, Schwan V, Miesbach W et al (2013) Rare bleeding disorders are associated with depression and anxiety. Hamostaseologie 33:S64–S68PubMed
11.
Zurück zum Zitat Group W, others (1998) The World Health Organization quality of life assessment (WHOQOL): development and general psychometric properties. Soc Sci Med 46:1569–1585CrossRef Group W, others (1998) The World Health Organization quality of life assessment (WHOQOL): development and general psychometric properties. Soc Sci Med 46:1569–1585CrossRef
12.
Zurück zum Zitat Mokhtar GM, Farid SM, Shaker NM, Farrag KE (2014) Health-related quality of life of Egyptian children with immune thrombocytopenia and their parents. J Pediatr Hematol Oncol 36:194–199CrossRefPubMed Mokhtar GM, Farid SM, Shaker NM, Farrag KE (2014) Health-related quality of life of Egyptian children with immune thrombocytopenia and their parents. J Pediatr Hematol Oncol 36:194–199CrossRefPubMed
13.
Zurück zum Zitat Heitink-Pollé KMJ, Haverman L, Annink KV et al (2014) Health-related quality of life in children with newly diagnosed immune thrombocytopenia. Haematologica 99:1525–1531CrossRefPubMedCentralPubMed Heitink-Pollé KMJ, Haverman L, Annink KV et al (2014) Health-related quality of life in children with newly diagnosed immune thrombocytopenia. Haematologica 99:1525–1531CrossRefPubMedCentralPubMed
14.
Zurück zum Zitat Rodeghiero F, Stasi R, Gernsheimer T et al (2009) Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood 113:2386–2393CrossRef Rodeghiero F, Stasi R, Gernsheimer T et al (2009) Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood 113:2386–2393CrossRef
15.
Zurück zum Zitat Varni JW, Seid M, Rode CA (1999) The PedsQL: measurement model for the pediatric quality of life inventory. Med Care 37:126–139CrossRef Varni JW, Seid M, Rode CA (1999) The PedsQL: measurement model for the pediatric quality of life inventory. Med Care 37:126–139CrossRef
16.
Zurück zum Zitat Sheehan DV, Lecrubier Y, Sheehan KH et al (1997) The validity of the Mini International Neuropsychiatric Interview (MINI) according to the SCID-P and its reliability. Eur Psychiatry 12:232–241CrossRef Sheehan DV, Lecrubier Y, Sheehan KH et al (1997) The validity of the Mini International Neuropsychiatric Interview (MINI) according to the SCID-P and its reliability. Eur Psychiatry 12:232–241CrossRef
17.
Zurück zum Zitat Ibrahim M, Bishry Z, Hamed A (2002) Comparison of mini international neuropsychiatric interview for children (MINI-KID) with the schedules for affective disorders and schizophrenia for school aged children, present and lifetime version (KSADS-PL). In: Egyptian sample presenting with childhoo. MD thesis, Ain Shams University Ibrahim M, Bishry Z, Hamed A (2002) Comparison of mini international neuropsychiatric interview for children (MINI-KID) with the schedules for affective disorders and schizophrenia for school aged children, present and lifetime version (KSADS-PL). In: Egyptian sample presenting with childhoo. MD thesis, Ain Shams University
18.
Zurück zum Zitat Neunert C, Lim W, Crowther M et al (2011) The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood 117:4190–4207CrossRefPubMed Neunert C, Lim W, Crowther M et al (2011) The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood 117:4190–4207CrossRefPubMed
19.
Zurück zum Zitat Alam MM (2014) Idiopathic thrombocytopenic purpura in children: a 10 years experience at tertiary care hospital. J Pak Med Assoc 64:1358–1362PubMed Alam MM (2014) Idiopathic thrombocytopenic purpura in children: a 10 years experience at tertiary care hospital. J Pak Med Assoc 64:1358–1362PubMed
20.
Zurück zum Zitat Nazari SH, Abdollah Gorji F, Sadeghi-Koupai MT (2012) Epidemiology of idiopathic thrombocytopenic purpura in children. Iran J Pediatr Hematol Oncol 2:35–39 Nazari SH, Abdollah Gorji F, Sadeghi-Koupai MT (2012) Epidemiology of idiopathic thrombocytopenic purpura in children. Iran J Pediatr Hematol Oncol 2:35–39
21.
Zurück zum Zitat Journeycake JM (2012) Childhood immune thrombocytopenia: role of rituximab, recombinant thrombopoietin, and other new therapeutics. ASH Educ Progr B 2012:444–449 Journeycake JM (2012) Childhood immune thrombocytopenia: role of rituximab, recombinant thrombopoietin, and other new therapeutics. ASH Educ Progr B 2012:444–449
22.
Zurück zum Zitat Neunert CE, Buchanan GR, Imbach P et al (2008) Severe hemorrhage in children with newly diagnosed immune thrombocytopenic purpura. Blood 112:4003–4008CrossRefPubMedCentralPubMed Neunert CE, Buchanan GR, Imbach P et al (2008) Severe hemorrhage in children with newly diagnosed immune thrombocytopenic purpura. Blood 112:4003–4008CrossRefPubMedCentralPubMed
23.
Zurück zum Zitat Zhang H, Wang L, Quan M et al (2016) Health-related quality of life in children with chronic immune thrombocytopenia in China. Health Qual Life Outcomes 14:45CrossRefPubMedCentralPubMed Zhang H, Wang L, Quan M et al (2016) Health-related quality of life in children with chronic immune thrombocytopenia in China. Health Qual Life Outcomes 14:45CrossRefPubMedCentralPubMed
24.
Zurück zum Zitat Mathias SD, Gao SK, Miller KL et al (2008) Impact of chronic immune thrombocytopenic purpura (ITP) on health-related quality of life: a conceptual model starting with the patient perspective. Health Qual Life Outcomes 6:13CrossRefPubMedCentralPubMed Mathias SD, Gao SK, Miller KL et al (2008) Impact of chronic immune thrombocytopenic purpura (ITP) on health-related quality of life: a conceptual model starting with the patient perspective. Health Qual Life Outcomes 6:13CrossRefPubMedCentralPubMed
25.
26.
Zurück zum Zitat McMillan R, Bussel JB, George JN et al (2008) Self-reported health-related quality of life in adults with chronic immune thrombocytopenic purpura. Am J Hematol 83:150–154CrossRefPubMed McMillan R, Bussel JB, George JN et al (2008) Self-reported health-related quality of life in adults with chronic immune thrombocytopenic purpura. Am J Hematol 83:150–154CrossRefPubMed
28.
Zurück zum Zitat Rosthøj S, Rajantie J, Treutiger I et al (2012) Duration and morbidity of chronic immune thrombocytopenic purpura in children: five-year follow-up of a nordic cohort. Acta Paediatr 101:761–766CrossRefPubMed Rosthøj S, Rajantie J, Treutiger I et al (2012) Duration and morbidity of chronic immune thrombocytopenic purpura in children: five-year follow-up of a nordic cohort. Acta Paediatr 101:761–766CrossRefPubMed
Metadaten
Titel
Psychiatric Disorders and Quality of Life in Egyptian Patients with Chronic Immune Thrombocytopenic Purpura: A Single Center Study
verfasst von
Sohier Yahia
Yahya Wahba
Abdel-Hady El-Gilany
Suzy Abdelmabood
Mohamed Adel El-Hadidy
Ahmad Darwish
Ahmed K. Mansour
Publikationsdatum
11.10.2018
Verlag
Springer India
Erschienen in
Indian Journal of Hematology and Blood Transfusion / Ausgabe 2/2019
Print ISSN: 0971-4502
Elektronische ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-018-1031-0

Weitere Artikel der Ausgabe 2/2019

Indian Journal of Hematology and Blood Transfusion 2/2019 Zur Ausgabe

Nodal-negativ nach neoadjuvanter Chemo: Axilladissektion verzichtbar?

03.05.2024 Mammakarzinom Nachrichten

Wenn bei Mammakarzinomen durch eine neoadjuvante Chemotherapie ein Downstaging von nodal-positiv zu nodal-negativ gelingt, scheint es auch ohne Axilladissektion nur selten zu axillären Rezidiven zu kommen.

Wo hapert es noch bei der Umsetzung der POMGAT-Leitlinie?

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Bestrahlung nach Prostatektomie: mehr Schaden als Nutzen?

02.05.2024 Prostatakarzinom Nachrichten

Eine adjuvante Radiotherapie nach radikaler Prostata-Op. bringt den Betroffenen wahrscheinlich keinen Vorteil. Im Gegenteil: Durch die Bestrahlung steigt offenbar das Risiko für Harn- und Stuhlinkontinenz.

Endlich: Zi zeigt, mit welchen PVS Praxen zufrieden sind

IT für Ärzte Nachrichten

Darauf haben viele Praxen gewartet: Das Zi hat eine Liste von Praxisverwaltungssystemen veröffentlicht, die von Nutzern positiv bewertet werden. Eine gute Grundlage für wechselwillige Ärzte und Psychotherapeuten.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.